Another Sleep Apnea Drug May Be on the Horizon for a Broader Population

(MedPage Today) — CHICAGO — A novel combination drug targeting neuromuscular dysfunction in obstructive sleep apnea (OSA) reduced severity of the condition in two pivotal randomized trials.
In the SynAIRgy trial, those who received at least…